Peng R - Search Results

1

Potential pitfalls of CRISPR/Cas9-mediated genome editing.

Peng R, Lin G, Li J. Peng R, et al. FEBS J. 2016 Apr;283(7):1218-31. doi: 10.1111/febs.13586. Epub 2015 Nov 27. FEBS J. 2016. PMID: 26535798 Review.

2

Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China.

Li Y, Zhang R, Peng R, Ding J, Han Y, Wang G, Zhang K, Lin G, Li J. Li Y, et al. Among authors: peng r. J Thorac Oncol. 2016 Jun;11(6):924-9. doi: 10.1016/j.jtho.2016.03.004. Epub 2016 Mar 14. J Thorac Oncol. 2016. PMID: 26988569

3

Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer-Related Single-Nucleotide Variants and Copy Number Variants Using Simulated Cell-Free DNA.

Yang X, Chu Y, Zhang R, Han Y, Zhang L, Fu Y, Li D, Peng R, Li D, Ding J, Li Z, Zhao M, Zhang K, Lu T, Yi L, Wu Q, Lin G, Xie J, Liu T, Yang L, Yi X, Li J. Yang X, et al. Among authors: peng r. J Mol Diagn. 2017 Jul;19(4):525-536. doi: 10.1016/j.jmoldx.2017.04.007. Epub 2017 May 11. J Mol Diagn. 2017. PMID: 28502728

4

Synthetic Circulating Cell-free DNA as Quality Control Materials for Somatic Mutation Detection in Liquid Biopsy for Cancer.

Zhang R, Peng R, Li Z, Gao P, Jia S, Yang X, Ding J, Han Y, Xie J, Li J. Zhang R, et al. Among authors: peng r. Clin Chem. 2017 Sep;63(9):1465-1475. doi: 10.1373/clinchem.2017.272559. Epub 2017 Jul 18. Clin Chem. 2017. PMID: 28720677

5

CRISPR/Cas9 Technology-Based Xenograft Tumors as Candidate Reference Materials for Multiple EML4-ALK Rearrangements Testing.

Peng R, Zhang R, Lin G, Yang X, Li Z, Zhang K, Zhang J, Li J. Peng R, et al. J Mol Diagn. 2017 Sep;19(5):766-775. doi: 10.1016/j.jmoldx.2017.06.003. Epub 2017 Jul 18. J Mol Diagn. 2017. PMID: 28732214

6

A novel cell line generated using the CRISPR/Cas9 technology as universal quality control material for KRAS G12V mutation testing.

Jia S, Zhang R, Lin G, Peng R, Gao P, Han Y, Fu Y, Ding J, Wu Q, Zhang K, Xie J, Li J. Jia S, et al. Among authors: peng r. J Clin Lab Anal. 2018 Jun;32(5):e22391. doi: 10.1002/jcla.22391. Epub 2018 Jan 30. J Clin Lab Anal. 2018. PMID: 29380513 Free PMC article.

7

Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.

Lin G, Zhang K, Peng R, Han Y, Xie J, Li J. Lin G, et al. Among authors: peng r. J Mol Diagn. 2018 May;20(3):373-380. doi: 10.1016/j.jmoldx.2018.02.002. J Mol Diagn. 2018. PMID: 29680088

8

The applications of CRISPR/Cas system in molecular detection.

Zhou L, Peng R, Zhang R, Li J. Zhou L, et al. Among authors: peng r. J Cell Mol Med. 2018 Dec;22(12):5807-5815. doi: 10.1111/jcmm.13925. Epub 2018 Oct 19. J Cell Mol Med. 2018. PMID: 30338908 Free PMC article. Review.

9

Continual Improvement of the Reliability of EML4-ALK Rearrangement Detection in Non-Small-Cell Lung Cancer: A Long-Term Comparison of ALK Detection in China.

Peng R, Zhang R, Zhang J, Tan P, Han Y, Zhang K, Lin G, Xie J, Li J. Peng R, et al. J Mol Diagn. 2020 Jul;22(7):876-884. doi: 10.1016/j.jmoldx.2020.03.007. Epub 2020 Apr 14. J Mol Diagn. 2020. PMID: 32302779

10

The miR-21 potential of serving as a biomarker for liver diseases in clinical practice.

Zhang J, Li D, Zhang R, Gao P, Peng R, Li J. Zhang J, et al. Among authors: peng r. Biochem Soc Trans. 2020 Oct 30;48(5):2295-2305. doi: 10.1042/BST20200653. Biochem Soc Trans. 2020. PMID: 33119045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results